|
A2: age at the time of event - 64 years.The event is considered as misuse since the end user was using improper device for their medical condition and/or known risk factors as the end user was allergic to band aid adhesives.Based on the available information, this event is deemed to be a serious injury.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number: reporting site: 1049092, manufacturing site: 9618003.
|
|
The end user reported that she had peristomal skin complications (psc), describing that the peristomal skin under the mass and tape collar was itchy and had a red rash.The wear time was one day.She was seen at the local wound clinic and diagnosed with a fungal infection.She had been given oral nystatin to take.End user stated that the area under the mass had improved, but the area under the tape collar had not.She felt that she had a combination of a yeast infection to the mass and an allergic reaction to the tape.She did not require any medical attention and was not prescribed any medication for an allergic reaction.The patient continued to use the product.No photo was available at this time.
|
|
Additional information - this emdr is being submitted to include the below: h6: investigation results under imdrf cause investigation code, imdrf investigation findings, imdrf cause conclusions h10: investigation summary photograph, video and/or physical sample evaluation: no photographs associated with this case were received and no unused return sample was expected.Batch record revision results: lot 3d00579 was manufactured on 05/apr/2023, in ffs#1 line, with a total of (b)(4) market units (mkus).The complaint investigator performed a batch record review on 12/oct/2023, to verify if all the applicable procedures were followed and no issues were found; all the components for assembly were correct per bill of materials (bom) and all the tooling information documented was also correct, system application product (sap) material identification (id) 1709735 and manufacturing order (b)(4).The production process, in-process control, testing results and packaging of products was run according to the applicable process instruction.Historical complaints review: on 12/oct/2023, complaint investigator ran a query in database from 01/jan/2022 to 03/oct/2023 in order to verify the complaints reported for the lot number 3d00579 for the malfunction code ¿clinical misindication, end user is using improper device for their medical condition and/or known risk factors¿ and as result, no additional complaints were found.Historical nonconformance review: on 12/oct/2023, complaint investigator ran a query in database looking for any in process nonconformance / corrective and preventive actions (capa (s)) associated to the malfunction code ¿clinical misindication, end user is using improper device for their medical condition and/or known risk factors¿ for the lot number 3d00579 and as result, no nonconformance / corrective and preventive actions (capa (s)) for this malfunction code were generated during the manufacturing process of the referenced lot.Defect rate analysis / current quality controls: there is no criteria not met, since during the investigation, this defect could not be attributed to the manufacturing process and there is no established a criterion for this type of defect.Conclusions: no objective evidence was received such as a photo or sample, for this reason, we cannot conclude that the product does not meet specifications.The review of the batch record showed that all relevant tests required during the manufacturing process and final product release had been fulfilled and met the requirements.No nonconformity has been registered during the manufacturing process of the affected lot for the malfunction code ¿clinical misindication, end user is using improper device for their medical condition and/or known risk factors¿.No additional complaints were reported for lot affected related to the malfunction code ¿clinical misindication, end user is using improper device for their medical condition and/or known risk factors¿.Based on this, no negative trend was identified.This issue will be monitored through the post market product monitoring review process.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number reporting site: 1049092 manufacturing site: 9618003.
|